Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Samantha Rix
Telephone
+44 7385972251
Country
United Kingdom
Region code
UKK11 - Bristol, City of
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Clinical Therapeutic Apheresis and Extracorporeal Photopheresis Systems
Reference number
C192220
two.1.2) Main CPV code
- 33100000 - Medical equipments
two.1.3) Type of contract
Supplies
two.1.4) Short description
Please note this is not the start of a procurement process. A separate contract notice will be published to cover this requirement.
two.1.5) Estimated total value
Value excluding VAT: £32,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 50421000 - Repair and maintenance services of medical equipment
- 33140000 - Medical consumables
two.2.3) Place of performance
NUTS codes
- UKK11 - Bristol, City of
Main site or place of performance
England and Wales
two.2.4) Description of the procurement
NHS Blood and Transplant (NHSBT) is a Special Health Authority and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals.
The NHSBT Therapeutic Apheresis Service (TAS) provide lifesaving and life-enhancing therapies to adults and children across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales (Bristol, London, Oxford, Leeds, Sheffield, Liverpool, Manchester, Birmingham, Plymouth, Cardiff and the Clatterbridge Cancer Centre) with each unit is led by a team of specialist medical and nursing staff.
Prior to commencing a formal procurement process and to help inform strategy requirements, NHSBT would like to consult the market to establish the level of interest for the purchase of therapeutic apheresis machines, consumables and maintenance, to support provision of the following services:
1. NEW Therapeutic Apheresis Systems for Extracorporeal Photopheresis (ECP), associated consumables and maintenance.
2. NEW Therapeutic Apheresis Systems for Multi-functional Apheresis Collection, Exchange and Depletion Procedures, associated consumables and maintenance.
3. Consumables, Maintenance and Repair of EXISTING NHSBT owned Cellex ECP Machines.
4. Consumables, Maintenance and Repair of EXISTING NHSBT owned Optia Multi-Apheresis Machines.
NHST may invite those organisations who express an interest in the Prior Information Notice to Supplier engagement meetings to be held in October/November/December 2023 (dates to be confirmed).
Any interested organisations are required to express their interest to samantha.rix@nhsbt.nhs.uk by 17:00 31 4 September 2023.
If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised.
Further information e.g. draft technical specification, award criteria, timescales maybe release for consultation purposes only, to organisations who express an interest in this PIN.
Please note that all details are subject to change.
two.3) Estimated date of publication of contract notice
1 April 2024
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes